157 related articles for article (PubMed ID: 29582230)
1. Binding free energy calculations to rationalize the interactions of huprines with acetylcholinesterase.
Nascimento ÉCM; Oliva M; Andrés J
J Comput Aided Mol Des; 2018 May; 32(5):607-622. PubMed ID: 29582230
[TBL] [Abstract][Full Text] [Related]
2. Binding Analysis of Some Classical Acetylcholinesterase Inhibitors: Insights for a Rational Design Using Free Energy Perturbation Method Calculations with QM/MM MD Simulations.
Nascimento ÉCM; Oliva M; Świderek K; Martins JBL; Andrés J
J Chem Inf Model; 2017 Apr; 57(4):958-976. PubMed ID: 28406297
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies.
Pang YP; Kozikowski AP
J Comput Aided Mol Des; 1994 Dec; 8(6):669-81. PubMed ID: 7738603
[TBL] [Abstract][Full Text] [Related]
4. In-situ synthesis of a tacrine-triazole-based inhibitor of acetylcholinesterase: configurational selection imposed by steric interactions.
Senapati S; Cheng Y; McCammon JA
J Med Chem; 2006 Oct; 49(21):6222-30. PubMed ID: 17034128
[TBL] [Abstract][Full Text] [Related]
5. 3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates.
Dvir H; Wong DM; Harel M; Barril X; Orozco M; Luque FJ; Muñoz-Torrero D; Camps P; Rosenberry TL; Silman I; Sussman JL
Biochemistry; 2002 Mar; 41(9):2970-81. PubMed ID: 11863435
[TBL] [Abstract][Full Text] [Related]
6. Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase.
Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Dec; 42(25):5110-9. PubMed ID: 10602696
[TBL] [Abstract][Full Text] [Related]
7. The 3D-QSAR study of 110 diverse, dual binding, acetylcholinesterase inhibitors based on alignment independent descriptors (GRIND-2). The effects of conformation on predictive power and interpretability of the models.
Vitorović-Todorović MD; Cvijetić IN; Juranić IO; Drakulić BJ
J Mol Graph Model; 2012 Sep; 38():194-210. PubMed ID: 23073222
[TBL] [Abstract][Full Text] [Related]
8. Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Camps P; Muñoz-Torrero D
Mini Rev Med Chem; 2001 Jul; 1(2):163-74. PubMed ID: 12369981
[TBL] [Abstract][Full Text] [Related]
9. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
Zhang S; Hou B; Yang H; Zuo Z
Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of femtomolar inhibitors for acetylcholinesterase subtype selectivity: insights from computational simulations.
Zhu XL; Yu NX; Hao GF; Yang WC; Yang GF
J Mol Graph Model; 2013 Apr; 41():55-60. PubMed ID: 23500627
[TBL] [Abstract][Full Text] [Related]
11. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
12. Studies on a new series of THA analogues: effects of the aromatic residues that line the gorge of AChE.
Pomponi M; Marta M; Colella A; Sacchi S; Patamia M; Gatta F; Capone F; Oliverio A; Pavone F
FEBS Lett; 1997 Jun; 409(2):155-60. PubMed ID: 9202137
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids.
Alcalá Mdel M; Vivas NM; Hospital S; Camps P; Muñoz-Torrero D; Badia A
Neuropharmacology; 2003 May; 44(6):749-55. PubMed ID: 12681373
[TBL] [Abstract][Full Text] [Related]
14. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
Ghosh S; Chandar NB; Jana K; Ganguly B
J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405
[TBL] [Abstract][Full Text] [Related]
15. Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.
Rydberg EH; Brumshtein B; Greenblatt HM; Wong DM; Shaya D; Williams LD; Carlier PR; Pang YP; Silman I; Sussman JL
J Med Chem; 2006 Sep; 49(18):5491-500. PubMed ID: 16942022
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and docking studies of alkylene-linked dimers of (-)-huperzine A.
Jin G; Luo X; He X; Jiang H; Zhang H; Bai D
Arzneimittelforschung; 2003; 53(11):753-7. PubMed ID: 14677369
[TBL] [Abstract][Full Text] [Related]
17. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
Ariel N; Ordentlich A; Barak D; Bino T; Velan B; Shafferman A
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):95-102. PubMed ID: 9742217
[TBL] [Abstract][Full Text] [Related]
18. Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method.
Kitisripanya N; Saparpakorn P; Wolschann P; Hannongbua S
Nanomedicine; 2011 Feb; 7(1):60-8. PubMed ID: 20851778
[TBL] [Abstract][Full Text] [Related]
19. Ensembles of Bayesian-regularized genetic neural networks for modeling of acetylcholinesterase inhibition by huprines.
Fernández M; Caballero J
Chem Biol Drug Des; 2006 Oct; 68(4):201-12. PubMed ID: 17105484
[TBL] [Abstract][Full Text] [Related]
20. Induced fit in mouse acetylcholinesterase upon binding a femtomolar inhibitor: a molecular dynamics study.
Senapati S; Bui JM; McCammon JA
J Med Chem; 2005 Dec; 48(26):8155-62. PubMed ID: 16366597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
